D. Mcvey

Safety and Efficacy of Ulimorelin Administered Postoperatively to Accelerate Recovery of Gastrointestinal Motility Following Partial Bowel Resection: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

F. Rousseau, J. Quinn, E. Mondou, 2013, Diseases of the colon and rectum.

Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial

M. Childs, M. Bigard, D. Pouchain, 2012, BMC Gastroenterology.

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.

J. Williams, D. Mcvey, H. Chen, 1991, The Journal of antimicrobial chemotherapy.

A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease.

V. Viswanadhan, B. Kulkarni, J. Aiyar, 2016, Journal of medicinal chemistry.

Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.

D. Livermore, G. Bonfiglio, D. Mcvey, 1993, The Journal of antimicrobial chemotherapy.

Codes and Abbreviations for Approved or Effectively Published Names of Genera of Bacteria Published from January 1980 to October 1985 and of Generally Recognized Yeast Genera

Micah I. Krichevsky, Cynthia A. Walczak, M. Rogosa, 1986 .

Safety and Efficacy of Ulimorelin Administered Postoperatively to Accelerate Recovery of Gastrointestinal Motility Following Partial Bowel Resection: Results of Two Randomized, Placebo-Controlled Phase 3 Trials

F. Rousseau, J. Quinn, E. Mondou, 2013, Diseases of the colon and rectum.